BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.7248
+0.0044 (0.61%)
At close: Aug 13, 2025, 4:00 PM
0.7201
-0.0047 (-0.65%)
After-hours: Aug 13, 2025, 7:32 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $12.76 million as of August 13, 2025. Its market cap has decreased by -8.21% in one year.
Market Cap
12.76M
Enterprise Value
-233.93K
1-Year Change
-8.21%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $12.76M, a decrease of -50.93%. That is a compound annual growth rate of -14.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 4.90M | -80.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |